Kelly Constable
Director/Board Member at ProTA Therapeutics Pty Ltd.
Profile
Ms. Kelly Constable is a Senior Advisor at Lumira Ventures and an Advisory Council at Medicines Australia.
She is on the Board of Directors at CERA Technologies Pty Ltd.
and ProTA Therapeutics Pty Ltd.
Ms. Constable was previously employed as a Venture partner by OneVentures Management Pty Ltd., a Board of Directors by Oculo Therapy LLC, a Chief strategy Officer by Omico Corp., a Board of Director & CEO by Genome One Pty Ltd., a Director of global marketing by Amgen AB, and a Senior product manager by Abbott Laboratories.
She received her undergraduate degree from the University of Tennessee.
Kelly Constable active positions
Companies | Position | Start |
---|---|---|
Medicines Australia
Medicines Australia Pharmaceuticals: MajorHealth Technology Medicines Australia is a non-profit organization which designs, develops, and implements health and industry policies for pharmaceutical industry. It builds and maintains relationships with government for fair reimbursement of medicines to ensure the continuation of a viable medicines industry, administers the Medicines Australia Code of Conduct which sets the standard for the ethical marketing and promotion of prescription medicines, and provides specialist advice to member companies. The organization is headquartered in Deakin, Australia. | Consultant / Advisor | 31/07/2020 |
CERA Technologies Pty Ltd.
CERA Technologies Pty Ltd. Packaged SoftwareTechnology Services Part of Revenio Group Oyj, CERA Technologies Pty Ltd. is a world-leading eye care platform that connects ophthalmology, optometry, primary care, emergency rooms, and patients to share clinical information and enhance referrals, triage, and collaborative care. The company is based in Melbourne, Australia. The technology enhances collaboration, bridges disconnected data silos, and delivers fast, efficient patient care. The platform is designed to share clinical correspondence securely and instantly between health care professionals, addressing the known challenges in clinical communication between a collaborative care network of health care providers. The company complies with the data protection regulations of HIPAA, the GDPR, and the Australian Privacy Principles. The company was founded in 2015 by Kate Taylor, Jonathan Crowston. Kate Taylor has been the CEO since 2015. CERA Technologies was acquired by Revenio Group Oyj on April 27, 2021 for $14.42 million. | Director/Board Member | 31/01/2020 |
ProTA Therapeutics Pty Ltd.
ProTA Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology ProTA Therapeutics Pty Ltd. manufactures pharmaceutical products. The company was founded by Mimi Tang on September 23, 2016 and is headquartered in Melbourne, Australia. | Director/Board Member | 30/09/2018 |
Kira Biotech Pty Ltd.
Kira Biotech Pty Ltd. BiotechnologyHealth Technology Kira Biotech Pty Ltd. operates as biotechnology company which develops novel immunomodulatory compounds for the treatment of immune system disorders. The company was founded by Georgina Clark is headquartered in Brisbane, Australia. | Director/Board Member | - |
Former positions of Kelly Constable
Companies | Position | End |
---|---|---|
OneVentures Management Pty Ltd.
OneVentures Management Pty Ltd. Investment ManagersFinance OneVentures Management Pty Ltd. (OneVentures) is a venture capital firm, a susbidiary of Andover Group Pty Ltd was founded in 2006 by Dr Michelle Deaker. The firm is headquartered in Australia. | Consultant / Advisor | 01/10/2023 |
OMICO CORPORATION | Corporate Officer/Principal | 01/12/2019 |
Oculo Therapy LLC
Oculo Therapy LLC Miscellaneous Commercial ServicesCommercial Services Oculo Therapy LLC is an American biotechnology company. | Director/Board Member | 01/12/2019 |
Genome One Pty Ltd. | Chief Executive Officer | 30/08/2018 |
Amgen AB
Amgen AB BiotechnologyHealth Technology Amgen AB conducts biotechnology research and experimental development. It focuses on the following therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. The company was founded in 1980 and is headquartered in Solna, Sweden. | Director/Board Member | 01/12/2016 |
Training of Kelly Constable
University of Tennessee | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ABBOTT LABORATORIES | Health Technology |
OMICO CORPORATION | Finance |
Private companies | 8 |
---|---|
Medicines Australia
Medicines Australia Pharmaceuticals: MajorHealth Technology Medicines Australia is a non-profit organization which designs, develops, and implements health and industry policies for pharmaceutical industry. It builds and maintains relationships with government for fair reimbursement of medicines to ensure the continuation of a viable medicines industry, administers the Medicines Australia Code of Conduct which sets the standard for the ethical marketing and promotion of prescription medicines, and provides specialist advice to member companies. The organization is headquartered in Deakin, Australia. | Health Technology |
CERA Technologies Pty Ltd.
CERA Technologies Pty Ltd. Packaged SoftwareTechnology Services Part of Revenio Group Oyj, CERA Technologies Pty Ltd. is a world-leading eye care platform that connects ophthalmology, optometry, primary care, emergency rooms, and patients to share clinical information and enhance referrals, triage, and collaborative care. The company is based in Melbourne, Australia. The technology enhances collaboration, bridges disconnected data silos, and delivers fast, efficient patient care. The platform is designed to share clinical correspondence securely and instantly between health care professionals, addressing the known challenges in clinical communication between a collaborative care network of health care providers. The company complies with the data protection regulations of HIPAA, the GDPR, and the Australian Privacy Principles. The company was founded in 2015 by Kate Taylor, Jonathan Crowston. Kate Taylor has been the CEO since 2015. CERA Technologies was acquired by Revenio Group Oyj on April 27, 2021 for $14.42 million. | Technology Services |
ProTA Therapeutics Pty Ltd.
ProTA Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology ProTA Therapeutics Pty Ltd. manufactures pharmaceutical products. The company was founded by Mimi Tang on September 23, 2016 and is headquartered in Melbourne, Australia. | Health Technology |
Genome One Pty Ltd. | |
Amgen AB
Amgen AB BiotechnologyHealth Technology Amgen AB conducts biotechnology research and experimental development. It focuses on the following therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. The company was founded in 1980 and is headquartered in Solna, Sweden. | Health Technology |
Oculo Therapy LLC
Oculo Therapy LLC Miscellaneous Commercial ServicesCommercial Services Oculo Therapy LLC is an American biotechnology company. | Commercial Services |
OneVentures Management Pty Ltd.
OneVentures Management Pty Ltd. Investment ManagersFinance OneVentures Management Pty Ltd. (OneVentures) is a venture capital firm, a susbidiary of Andover Group Pty Ltd was founded in 2006 by Dr Michelle Deaker. The firm is headquartered in Australia. | Finance |
Kira Biotech Pty Ltd.
Kira Biotech Pty Ltd. BiotechnologyHealth Technology Kira Biotech Pty Ltd. operates as biotechnology company which develops novel immunomodulatory compounds for the treatment of immune system disorders. The company was founded by Georgina Clark is headquartered in Brisbane, Australia. | Health Technology |
- Stock Market
- Insiders
- Kelly Constable